145 related articles for article (PubMed ID: 3138311)
1. The suppressive effects of recombinant human tumor necrosis factor-alpha on normal and malignant myelopoiesis: synergism with interferon-gamma.
Herrmann F; Bambach T; Bonifer R; Lindemann A; Riedel D; Oster W; Mertelsmann R
Int J Cell Cloning; 1988 Jul; 6(4):241-61. PubMed ID: 3138311
[TBL] [Abstract][Full Text] [Related]
2. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
[TBL] [Abstract][Full Text] [Related]
3. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
Wisniewski D; Strife A; Atzpodien J; Clarkson BD
Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
[TBL] [Abstract][Full Text] [Related]
4. Differentiation-inducing effect of recombinant human tumor necrosis factor alpha and gamma-interferon in vitro on blast cells from patients with acute myeloid leukemia and myeloid blast crisis of chronic myeloid leukemia.
Geissler K; Tricot G; Leemhuis T; Walker E; Broxmeyer HE
Cancer Res; 1989 Jun; 49(11):3057-62. PubMed ID: 2497971
[TBL] [Abstract][Full Text] [Related]
5. Suppressive biological activity of a synthetic pentapeptide on highly enriched human and murine marrow hematopoietic progenitors: synergism with recombinant human tumor necrosis factor-alpha and interferon-gamma.
Lu L; Foa P; Chillemi F; Shen RN; Lin ZH; Carow C; Broxmeyer HE
Exp Hematol; 1989 Oct; 17(9):935-41. PubMed ID: 2506072
[TBL] [Abstract][Full Text] [Related]
6. Interferon-gamma and tumor necrosis factor-alpha suppress both early and late stages of hematopoiesis and induce programmed cell death.
Selleri C; Sato T; Anderson S; Young NS; Maciejewski JP
J Cell Physiol; 1995 Dec; 165(3):538-46. PubMed ID: 7593233
[TBL] [Abstract][Full Text] [Related]
7. Bone marrow fibroblast exposure to the inflammatory cytokines tumor necrosis factor-alpha and interferon-gamma increases adhesion of acute myeloid leukemia cells and alters the adhesive mechanism.
Bendall LJ; Kortlepel K; Gottlieb DJ
Exp Hematol; 1997 Feb; 25(2):132-9. PubMed ID: 9015213
[TBL] [Abstract][Full Text] [Related]
8. Studies of interferon as a regulator of hematopoietic cell proliferation.
Raefsky EL; Platanias LC; Zoumbos NC; Young NS
J Immunol; 1985 Oct; 135(4):2507-12. PubMed ID: 2411798
[TBL] [Abstract][Full Text] [Related]
9. Myelopoiesis-associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma tumors: gamma interferon plus tumor necrosis factor alpha synergistically reduces immune suppressor and tumor growth-promoting activities of bone marrow cells and diminishes tumor recurrence and metastasis.
Young MR; Wright MA
Cancer Res; 1992 Nov; 52(22):6335-40. PubMed ID: 1423279
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibition of human marrow granulocyte-macrophage progenitor cells by prostaglandin E and recombinant interferon-alpha, -beta, and -gamma and an effect mediated by tumor necrosis factor.
Pelus LM; Ottmann OG; Nocka KH
J Immunol; 1988 Jan; 140(2):479-84. PubMed ID: 3121745
[TBL] [Abstract][Full Text] [Related]
11. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
Ferret-Bernard S; Saï P; Bach JM
Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta 1 enhances the suppression of human hematopoiesis by tumor necrosis factor-alpha or recombinant interferon-alpha.
Sing GK; Keller JR; Ellingsworth LR; Ruscetti FW
J Cell Biochem; 1989 Feb; 39(2):107-15. PubMed ID: 2715197
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cells.
Beran M; O'Brien S; Andersson B; McCredie KB; Gutterman JU
Hematol Pathol; 1988; 2(2):65-71. PubMed ID: 3143710
[TBL] [Abstract][Full Text] [Related]
14. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
Papadakis V; Ferguson KF; Heller G; Kernan NA
Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
[TBL] [Abstract][Full Text] [Related]
15. Monocytes enhance gamma-interferon-induced inhibition of myeloid progenitor cell growth through secretion of tumor necrosis factor.
Cannistra SA; Groshek P; Griffin JD
Exp Hematol; 1988 Nov; 16(10):865-70. PubMed ID: 3139436
[TBL] [Abstract][Full Text] [Related]
16. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
Kerangueven F; Sempere C; Tabilio A; Mannoni P
Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
[TBL] [Abstract][Full Text] [Related]
17. Ciprofloxacin inhibits human hematopoietic cell growth: synergism with tumor necrosis factor and interferon.
Hahn T; Barak Y; Liebovich E; Malach L; Dagan O; Rubinstein E
Exp Hematol; 1991 Mar; 19(3):157-60. PubMed ID: 1899831
[TBL] [Abstract][Full Text] [Related]
18. Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.
Mamus SW; Oken MM; Zanjani ED
Exp Hematol; 1986 Dec; 14(11):1015-22. PubMed ID: 3780887
[TBL] [Abstract][Full Text] [Related]
19. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide suppression of human hematopoiesis in vitro. Contribution to inhibitory action of interferon-gamma and tumor necrosis factor-alpha.
Maciejewski JP; Selleri C; Sato T; Cho HJ; Keefer LK; Nathan CF; Young NS
J Clin Invest; 1995 Aug; 96(2):1085-92. PubMed ID: 7543491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
